Information:
Fel:
ID
33272
Beskrivning
Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT01339819
Länk
https://clinicaltrials.gov/show/NCT01339819
Nyckelord
Versioner (1)
- 2018-12-04 2018-12-04 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
4 december 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Atrial Fibrillation NCT01339819
Eligibility Atrial Fibrillation NCT01339819
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT01339819
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Atrial Fibrillation | Indication Anticoagulation Therapy Oral | CHA2DS2-VASc score
Item
patients with atrial fibrillation and an indication for oral anticoagulation (cha2ds2-vasc score≥ 1).
boolean
C0004238 (UMLS CUI [1])
C3146298 (UMLS CUI [2,1])
C0003281 (UMLS CUI [2,2])
C1527415 (UMLS CUI [2,3])
C4049268 (UMLS CUI [3])
C3146298 (UMLS CUI [2,1])
C0003281 (UMLS CUI [2,2])
C1527415 (UMLS CUI [2,3])
C4049268 (UMLS CUI [3])
Informed Consent | Informed Consent Patient Representative
Item
informed, written consent by the patient or her/his legally-authorized representative for participation in the study.
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
C1542147 (UMLS CUI [1,2])
Age
Item
age ≤18 years
boolean
C0001779 (UMLS CUI [1])
Shock, Cardiogenic
Item
cardiogenic shock
boolean
C0036980 (UMLS CUI [1])
dabigatran
Item
current therapy with dabigatran
boolean
C2348066 (UMLS CUI [1])
clopidogrel
Item
current, recent (2 weeks) or expected (1 week) clopidogrel therapy
boolean
C0070166 (UMLS CUI [1])
Medical contraindication Anticoagulation Therapy Oral
Item
contraindication for oral anticoagulation
boolean
C1301624 (UMLS CUI [1,1])
C0003281 (UMLS CUI [1,2])
C1527415 (UMLS CUI [1,3])
C0003281 (UMLS CUI [1,2])
C1527415 (UMLS CUI [1,3])
Hemorrhage
Item
active bleeding
boolean
C0019080 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Intolerance to Investigational New Drugs | Hypersensitivity Dabigatran | Intolerance to Dabigatran | Hypersensitivity Phenprocoumon | Intolerance to Phenprocoumon
Item
known allergy or intolerance to the study medications: dabigatran, phenprocoumon
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C2348066 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C2348066 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C0031444 (UMLS CUI [5,2])
C1744706 (UMLS CUI [6,1])
C0031444 (UMLS CUI [6,2])
C0013230 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C2348066 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C2348066 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C0031444 (UMLS CUI [5,2])
C1744706 (UMLS CUI [6,1])
C0031444 (UMLS CUI [6,2])